Anabio Technologies, welcomes Dr. Aidan Fitzsimons as the newest member of their rapidly growing team. Taking up the role of Commercial Director, Aidan brings a wealth of experience commercialising food ingredients and innovative technologies from a variety of roles based in Ireland, France, UK and USA. He joins from Dairygold Food Ingredients where he held a number of senior management positions since 2004.  Previous to that he worked in sales and R&D roles in Greencore and Ornua. Aidan holds a Henley MBA and a PhD from Dublin City University.

Aidan commented ‘I am thrilled to be joining the AnaBio team at such an exciting time in the company’s development and  am really looking forward to working with my new colleagues to bring  the consumer benefits offered by AnaBio’s  technologies to existing and new customers around the globe’.

 Dan McSweeney (AnaBio Chairman) commented I am delighted that Aidan has joined the AnaBio team and the AnaBio success story. His expertise and experience will be a great support for the team and I look forward to continued growth in the future”.

Sinead Bleiel (CEO) commented: “We are delighted to welcome Aidan, who has a proven track record in business development and commercialization. With Aidan’s support, AnaBio will soon be running and winning marathons on the global platform of functional foods and therapeutics. At AnaBio our motto is “Dream Big” and we will continue to implement this value with Aidan’s participation”.

AnaBio Technologies is a rapidly growing innovative Irish company providing micro-encapsulation expertise and contract manufacturing solutions for the stabilisation of food, pharmaceutical and animal health product ingredients. Our core technologies are patented for the stabilisation, protection and targeted release of sensitive ingredients. Applications for our targeted delivery technology including Probiotics, Omega Oils, Amino Acids, Peptides,  Nutraceuticals and  Active Pharmaceutical Ingredients (API’s). Our products have been clinically proven to significantly improve the stability and targeted delivery of active ingredients. AnaBio research scientists in collaboration with our customers and industry advisors are continually developing new commercial applications for our novel micro-encapsulation technologies.

For further information, please contact Dr. Sinéad Bleiel (